Pharmacology Research & Perspectives has now been accepted for indexing in PubMed Central (PMC).
Pharmacology Research & Perspectives invites authors to submit research articles and invites submission of several types of special articles. These are
Target validation - publication of negative findings including preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development.
Drug discovery reviews - strategy, hypotheses and data resulting in a successful therapeutic drug.
Frontiers in translational medicine - drug and target validation for an unmet therapeutic need
Pharmacological hypotheses - reviews that are oriented to inform a novel hypothesis
Replication Studies - work that refutes key findings (failed replication), and work that validates key findings
PR&P authors benefit from:
- Rapid peer review
- Full compliance with all open access mandates
- Authors retain copyright and articles are published under a Creative Commons License
- Discounts for ASPET and BPS society members and authors at institutions with Wiley accounts
In Memoriam: Darrell R. Abernethy, M.D. Ph.D.
It is with deep sadness that the Editorial Team at PR&P must convey the news that Darrell Abernethy, Editor in Chief of the Journal, has recently passed away. Darrell has been instrumental in raising the profile and quality of PR&P in both his roles on the Journal, first as Deputy Editor and then Editor. He has been a true inspiration to so many of our authors and editors who work in the field of pharmacology, very much a team player, providing considered and thoughtful responses. His wise counsel will be missed.
Rest in peace
PR&P Editorial Team
Darrell's obituary can be viewed on the ASPET website